Laparoscopic colectomy after transcatheter aortic valve implantation in an elderly patient with obstructive descending colon cancer and severe aortic stenosis: a case report.
Laparoscopic colectomy
Severe aortic stenosis
Transcatheter aortic valve implantation
Journal
Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125
Informations de publication
Date de publication:
24 Jun 2019
24 Jun 2019
Historique:
received:
19
04
2019
accepted:
12
06
2019
entrez:
26
6
2019
pubmed:
27
6
2019
medline:
27
6
2019
Statut:
epublish
Résumé
The demand for laparoscopic colectomy is increasing due to greater number of elderly colon cancer patients, and it is important to evaluate existing comorbidities to ensure perioperative safety. Aortic stenosis (AS) is one of the most common heart diseases in the elderly, and elderly cancer patients with severe AS may be considered ineligible for optimal cancer treatment if they cannot endure surgical aortic valve replacement (SAVR). Recently, transcatheter aortic valve implantation (TAVI) has become a valid option in patients who are high risk for SAVR. We herein present the first case of an elderly cancer patient with severe AS who underwent laparoscopic colectomy after TAVI. An 87-year-old woman with a history of multiple cardiovascular diseases was diagnosed with obstructive descending colon cancer and initially underwent colonic stenting. However, as preoperative echocardiography revealed severe AS, she underwent TAVI prior to the colectomy to reduce perioperative risk. TAVI was chosen instead of SAVR due to high SAVR mortality risk, and laparoscopic colectomy was performed 22 days after TAVI. Her postoperative course was uneventful, and she was discharged 14 days later without any deterioration in general condition. No recurrence was observed at more than 1 year, even without adjuvant therapy. TAVI facilitated subsequent laparoscopic colectomy in an elderly cancer patient with severe AS. Our case report shows that TAVI may enable further cancer treatment even in patients with severe AS, who may otherwise be considered not suitable for such treatments.
Sections du résumé
BACKGROUND
BACKGROUND
The demand for laparoscopic colectomy is increasing due to greater number of elderly colon cancer patients, and it is important to evaluate existing comorbidities to ensure perioperative safety. Aortic stenosis (AS) is one of the most common heart diseases in the elderly, and elderly cancer patients with severe AS may be considered ineligible for optimal cancer treatment if they cannot endure surgical aortic valve replacement (SAVR). Recently, transcatheter aortic valve implantation (TAVI) has become a valid option in patients who are high risk for SAVR. We herein present the first case of an elderly cancer patient with severe AS who underwent laparoscopic colectomy after TAVI.
CASE PRESENTATION
METHODS
An 87-year-old woman with a history of multiple cardiovascular diseases was diagnosed with obstructive descending colon cancer and initially underwent colonic stenting. However, as preoperative echocardiography revealed severe AS, she underwent TAVI prior to the colectomy to reduce perioperative risk. TAVI was chosen instead of SAVR due to high SAVR mortality risk, and laparoscopic colectomy was performed 22 days after TAVI. Her postoperative course was uneventful, and she was discharged 14 days later without any deterioration in general condition. No recurrence was observed at more than 1 year, even without adjuvant therapy.
CONCLUSION
CONCLUSIONS
TAVI facilitated subsequent laparoscopic colectomy in an elderly cancer patient with severe AS. Our case report shows that TAVI may enable further cancer treatment even in patients with severe AS, who may otherwise be considered not suitable for such treatments.
Identifiants
pubmed: 31236739
doi: 10.1186/s40792-019-0662-1
pii: 10.1186/s40792-019-0662-1
pmc: PMC6591332
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102Références
Surg Endosc. 2002 Jul;16(7):1121-43
pubmed: 12015619
Anesth Analg. 2003 Oct;97(4):958-63, table of contents
pubmed: 14500140
Lancet. 2005 May 14-20;365(9472):1718-26
pubmed: 15894098
Lancet Oncol. 2013 Mar;14(3):210-8
pubmed: 23395398
BMC Cancer. 2013 Nov 03;13:519
pubmed: 24180710
Circ Cardiovasc Interv. 2013 Dec;6(6):604-14
pubmed: 24221391
Prog Cardiovasc Dis. 2014 May-Jun;56(6):565-71
pubmed: 24838132
Can J Cardiol. 2014 Sep;30(9):962-70
pubmed: 24986049
Eur Heart J. 2014 Sep 14;35(35):2383-431
pubmed: 25086026
Lancet. 2015 Jun 20;385(9986):2485-91
pubmed: 25788231
Lancet. 2015 Jun 20;385(9986):2477-84
pubmed: 25788234
World J Gastroenterol. 2015 Dec 7;21(45):12843-50
pubmed: 26668508
Ann Surg. 2018 Jan;267(1):1-10
pubmed: 28463896
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1357-1365
pubmed: 28527771
Updates Surg. 2019 Mar;71(1):89-96
pubmed: 29663301
J Thorac Dis. 2018 May;10(5):E387-E390
pubmed: 29998000
J Cardiol Cases. 2018 Feb 14;17(5):163-166
pubmed: 30279882
Catheter Cardiovasc Interv. 2018 Dec 14;:null
pubmed: 30549397
Cardiovasc Interv Ther. 2019 Feb 13;:null
pubmed: 30758832
Surg Endosc. 2019 Mar 12;:null
pubmed: 30863928